• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ferritin-bearing lymphocytes in Hodgkin's disease.

作者信息

Koprivová H, Hermanská Z, Novák F, Blehová Z, Dienstbier Z

出版信息

Neoplasma. 1986;33(1):63-9.

PMID:3515213
Abstract

In view of the reported association of Hodgkin's disease (HD) and ferritin, ferritin-bearing lymphocytes were followed during 2-year period in 79 HD patients. Indirect immunofluorescent method was used to evaluate the percentage of ferritin positive cells. In 22 untreated patients a high percentage of ferritin-bearing circulating lymphocytes (mean value 37.3%) was found. In regard to the extent of the disease higher values were found in clinical stage III and IV (mean value 40.6%) as compared to the stage I and II (mean value 26.2%). Similarly, 17 patients in relapse and with disease progression had mean values 41%. These proportions of cells were significantly lower in 44 patients in complete remission with mean value of 8.7% (60 examinations). In 30 healthy controls the mean value was 1.4%. Repeatedly performed examinations of ferritin-bearing lymphocytes during the follow-up period in 17 patients showed to be an important prognostic tool. A negative correlation of ferritin-bearing lymphocytes with E-rosette-forming cells was found. Iron content in peripheral blood lymphocytes was confirmed cytochemically after pre-incubation with antiferritin antibody. The results support the presumed role of ferritin in impaired cellular immunity in HD and suggest diagnostic and prognostic value of the examination of ferritin-bearing lymphocytes in HD.

摘要

相似文献

1
Ferritin-bearing lymphocytes in Hodgkin's disease.
Neoplasma. 1986;33(1):63-9.
2
Cytotoxic activity of lymphocytes from patients with Hodgkin's disease.霍奇金病患者淋巴细胞的细胞毒性活性。
Clin Exp Immunol. 1975 Sep;21(3):376-83.
3
Some immunological parameters in Hodgkin's disease.霍奇金病的一些免疫学参数。
Neoplasma. 1988;35(1):51-60.
4
The significance of ferritin in malignant diseases.
Biomedicine. 1978 Jul-Aug;28(4):203-6.
5
Changes of the cellular immunity tests during the evolution of Hodgkin's disease.霍奇金病病程中细胞免疫试验的变化
Med Interne. 1983 Jul-Sep;21(3):203-15.
6
Ferritin-bearing lymphocytes in patients with cancer.癌症患者体内携带铁蛋白的淋巴细胞。
Cancer. 1984 Jan 15;53(2):267-71. doi: 10.1002/1097-0142(19840115)53:2<267::aid-cncr2820530214>3.0.co;2-8.
7
Normal active rosette-forming-cells in untreated patients with Hodgkin's disease.未经治疗的霍奇金病患者中的正常活性玫瑰花结形成细胞。
Biomedicine. 1977 Dec;27(9-10):322-4.
8
E-rosette inhibiting substance in Hodgkin's disease spleen extracts.霍奇金病脾脏提取物中的E玫瑰花结抑制物质。
Clin Exp Immunol. 1977 Sep;29(3):369-75.
9
Subpopulations of human T lymphocytes in patients with Hodgkin's disease before and after treatment.霍奇金病患者治疗前后的人类T淋巴细胞亚群
Neoplasma. 1982;29(2):149-59.
10
Autologous rosette-forming capacity of T-lymphocytes in Hodgkin's disease.霍奇金病中T淋巴细胞的自身玫瑰花结形成能力。
Acta Med Hung. 1984;41(2-3):113-9.

引用本文的文献

1
FBL blood test as a predictive marker of breast cancer in high risk women.FBL血液检测作为高危女性乳腺癌的预测标志物。
Med Oncol. 1997 Mar;14(1):39-42. doi: 10.1007/BF02990944.